Grants for Lung and Heart Transplant Research Co-funded by the ISHLT and ISHLT Foundation
The International Society for Heart and Lung Transplantation (ISHLT) announced over $257,000 USD in funding for research designed to improve care for patients with advanced heart and lung disease. These funds were provided by the ISHLT Foundation.
ISHLT Cardiogenic Shock Research Grant, supported by Johnson & Johnson MedTech | Heart Recovery

Dr. Steinhorn’s study aims to determine the effectiveness of tissue perfusion pressure measurement for patient care. With the funding, supported by Johnson & Johnson MedTech | Heart Recovery, Dr. Steinhorn’s team will study patient data to answer fundamental questions regarding unique patterns of how shock develops and best practices for pump adjustments and removal.

Dr. Ceulemans’ study examines CRISPR-Cas9 gene-editing, a molecular "scissor" that precisely targets and disrupts specific genes. With the funding, supported by Lung Bioengineering, Dr. Ceulemans’ team will study how this method aims to reduce ischemia-reperfusion injury by silencing harmful genes.
ISHLT Molecular Biomarker Study Using Artificial Intelligence/Machine Learning Analysis in Lung Transplantation Grant, supported by CareDx

With the funding supported by CareDx, Dr. Patel’s study aims to create a predictive tool that can assist transplant centers in identifying donor lungs that might disproportionately over- or under-perform, and help turn the "art" of extended criteria donor selection into a more exact science.
Awarded to: Glen Westall, FRACP, PhDLung transplants can save lives, but patients can develop CLAD post-transplant leading to a poor prognosis. With funding supported by CareDx, Dr. Westall’s team is working to develop an AI that can identify early signs of disease and predict the development of CLAD before it occurs, allowing doctors to intervene earlier with existing therapies, and manage immunosuppressive treatments more effectively.

